Alpine Immune Sciences Inc (ALPN)
64.96
-0.01
(-0.02%)
USD |
NASDAQ |
May 16, 16:00
64.96
0.00 (0.00%)
After-Hours: 18:07
Alpine Immune Sciences Market Cap: 4.456B for May 16, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 15, 2024 | 4.457B |
May 14, 2024 | 4.455B |
May 13, 2024 | 4.455B |
May 10, 2024 | 4.455B |
May 09, 2024 | 4.446B |
May 08, 2024 | 4.438B |
May 07, 2024 | 4.434B |
May 06, 2024 | 4.431B |
May 03, 2024 | 4.431B |
May 02, 2024 | 4.431B |
May 01, 2024 | 4.235B |
April 30, 2024 | 4.235B |
April 29, 2024 | 4.242B |
April 26, 2024 | 4.233B |
April 25, 2024 | 4.237B |
April 24, 2024 | 4.233B |
April 23, 2024 | 4.232B |
April 22, 2024 | 4.234B |
April 19, 2024 | 4.232B |
April 18, 2024 | 4.224B |
April 17, 2024 | 4.226B |
April 16, 2024 | 4.229B |
April 15, 2024 | 4.223B |
April 12, 2024 | 4.220B |
April 11, 2024 | 4.222B |
Date | Value |
---|---|
April 10, 2024 | 3.084B |
April 09, 2024 | 2.553B |
April 08, 2024 | 2.526B |
April 05, 2024 | 2.288B |
April 04, 2024 | 2.316B |
April 03, 2024 | 2.498B |
April 02, 2024 | 2.570B |
April 01, 2024 | 2.637B |
March 28, 2024 | 2.598B |
March 27, 2024 | 2.533B |
March 26, 2024 | 2.455B |
March 25, 2024 | 2.461B |
March 22, 2024 | 2.579B |
March 21, 2024 | 2.727B |
March 20, 2024 | 2.637B |
March 19, 2024 | 2.619B |
March 18, 2024 | 2.325B |
March 15, 2024 | 2.385B |
March 14, 2024 | 2.352B |
March 13, 2024 | 2.400B |
March 12, 2024 | 2.389B |
March 11, 2024 | 2.319B |
March 08, 2024 | 2.355B |
March 07, 2024 | 2.425B |
March 06, 2024 | 2.526B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
39.99M
Minimum
Mar 17 2020
4.457B
Maximum
May 15 2024
454.74M
Average
267.85M
Median
Market Cap Benchmarks
Vertex Pharmaceuticals Inc | 113.73B |
Eliem Therapeutics Inc | 227.02M |
Regeneron Pharmaceuticals Inc | 106.63B |
Vera Therapeutics Inc | 2.296B |
Eyenovia Inc | 38.90M |
Market Cap Related Metrics
PS Ratio | 62.19 |
Price to Book Value | 13.39 |
Price | 64.96 |
Earnings Yield | -0.99% |